The 2017 FARE National Food Allergy Conference is fast approaching. This year, the conference will be held at the Hyatt Regency San Antonio Riverwalk in San Antonio, TX. The conference is always a great opportunity to connect with other individuals and families with food allergy and to learn from food allergy experts. Over the next… Continue reading Meet the Speakers, Part 1: Dr. Scott Sicherer
A clinical trial conducted in Japan and published online in The Lancet (Dec. 8, 2016) found that the development of egg allergy in infants with eczema was dramatically reduced by aggressive eczema treatment combined with regular consumption of heated whole-egg powder. The prevalence of egg allergy was 79 percent lower among one-year-olds who had eaten… Continue reading In Babies Treated for Eczema, Early Introduction to Egg Limits Egg Allergy Prevalence
The National Institute of Allergy and Infectious Diseases (NIAID) has issued clinical guidelines recommending introduction of peanut-containing foods during infancy to limit the risk of developing peanut allergy. Published Jan. 5, 2017 in the Journal of Allergy and Clinical Immunology, the new NIAID Addendum Guidelines for the Prevention of Peanut Allergy in the United States… Continue reading New NIAID Guidelines Recommend Peanut-Containing Foods for Infants to Prevent Peanut Allergy
The FARE Clinical Network is expanding, and will now comprise 28 centers of excellence across the country. The FARE Clinical Network, dedicated to changing the face of food allergy care, is the only collaborative network of its kind. Five centers have recently joined the network, which now comprises 28 centers of excellence across the country.… Continue reading New Centers of Excellence Join the FARE Clinical Network
Younger brothers and sisters of peanut-allergic children are at higher risk for peanut sensitivity than children in general. However, a Canadian study published in the June 2016 issue of Allergy found that siblings whose peanut allergy tests were negative prior to introduction did not have an allergic response when they ate peanut for the first… Continue reading In Siblings, Peanut Tolerance Is Predicted by Negative Test Results Prior to Introduction
FARE recently received the Eugene Washington Engagement Award from the Patient-Centered Outcomes Research Institute (PCORI). FARE’s two-year project, “Empowering Patient Partners and Key Stakeholders to Develop a Patient-Centric Food Allergy Research Program,” seeks to address an unmet need in the research field by forming a partnership of patients empowered to work with other key stakeholders… Continue reading Interested in Providing the Patient Perspective in Research?
Earlier this month, FARE staff members attended the annual scientific meeting of the American Academy of Allergy, Asthma & Immunology, where researchers presented a number of new abstracts. Of interest to the food allergy community, both Aimmune Therapeutics and DBV Technologies presented new findings during the session for late-breaking abstracts. Aimmune Therapeutics Aimmune reported data… Continue reading Report from AAAAI: Aimmune and DBV Technologies Present New Findings